A model for attachment during invasion.

<p>An initial binding event is followed by receptor-induced dimerization, as in the DBP-RII∶DARC heterotrimer. This brings a second DBP-RII molecule in close proximity to a second DARC ectodomain in the DARC homodimer. A second binding event creates the DBP-RII∶DARC heterotetramer. DBP-RII molecules are in green and yellow and DARC19–30 molecules are in purple and blue. The DARC homodimer is represented by a homology model. A schematic for the stepwise assembly is shown at the bottom. Closed circle – bound DBP-RII, open circle – unbound DBP-RII.</p

Heterotrimer interface residues determined by PDBePISA [47]: All residues in the interface are listed sequentially and do not indicate interacting pairs.

<p>Heterotrimer interface residues determined by PDBePISA <a href="http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.1003869#ppat.1003869-Krissinel1" target="_blank">[47]</a>: All residues in the interface are listed sequentially and do not indicate interacting pairs.</p

Residues 14–43 of DARC contain the minimal binding region.

<p>¹H-¹⁵N-TROSY spectra of unbound DARC 1–60 (black) overlaid on ¹H-¹⁵N-TROSY spectra of DARC 1–60 in the presence of excess unlabelled DBP-RII (red). Sequence assignments are shown for the unbound DARC ¹H-¹⁵N-TROSY spectra. Peaks still visible in the presence of DBP-RII (red) are at DARC 1–60's N- and C- termini. Residues that disappear in the presence of DBP-RII are in the center of DARC and delineate the binding region.</p

Data collection and refinement statistics.

<p>Values in parentheses are for highest-resolution shell.</p><p>Data were collected on a single crystal for each dataset.</p

Isothermal titration calorimetry reveals step-wise binding of DARC to DBP-RII in solution.

<p>(<b>A</b>) A biphasic binding profile is observed indicating the formation of the heterotrimer at a molar ratio of 0.5 (<i>n₁</i> = 0.44±0.02, <i>K_d1</i> = 2183±125 nM, Δ<i>H₁</i> = −2663±69 cal/mol) and heterotetramer at a molar ratio of 1 (<i>n₂</i> = 0.50±0.02, <i>K_d2</i> = 88.5±26.6 nM, Δ<i>H₂</i> = −3338±23 cal/mol). The fit to the two independent site binding model is shown as a red line. Molar ratios are expressed as monomers of DBP-RII. Open circles denote unbound DBP, closed circles denote bound DBP. Titration of (<b>B</b>) PBS into DBP and (<b>C</b>) DARC into PBS reveals no observable profiles demonstrating the biphasic profile is due to DARC binding to DBP. In all cases, the top panel contains raw binding data, and the bottom panel changes in enthalpy associated with binding.</p

Binding interfaces of the DBP-RII∶DARC heterotrimer.

<p>(<b>A</b>) Global view of the DBP-RII∶DARC heterotrimer, showing (<b>B</b>) DARC monomer A interactions and (<b>C</b>) the DBP-RII homodimeric interface. DARC monomer A is in purple, DBP-RII monomer 1 is in green and DBP-RII monomer 2 is in yellow. Residue numbers are labeled and DARC residue labels are underlined.</p

Mapping polymorphic residues and inhibitory epitopes reveals targets of selective pressure.

<p>DBP-RII molecules are in green and yellow. DARC molecules are in purple and blue. DARC residue labels are underlined. (<b>A</b>) Nonsynonymous DARC polymorphisms in primates, residues colored in blue, which make critical contacts with DBP-RII provide a mechanism for inter-species transmission barriers. (<b>B</b>) Polymorphic DBP residues, in blue, are spread throughout the molecule. The most polymorphic region of DBP is the “DEK epitope” opposite the DARC14–43 binding site. (<b>C</b>) Inhibitory epitopes, in red and brown, map to the heterotetramer interface, DARC binding pockets and RBC proximal face of DBP-RII.</p

Heterotetramer interface residues determined by PDBePISA [47]: All residues in the interface are listed sequentially and do not indicate interacting pairs.

<p>Heterotetramer interface residues determined by PDBePISA <a href="http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.1003869#ppat.1003869-Krissinel1" target="_blank">[47]</a>: All residues in the interface are listed sequentially and do not indicate interacting pairs.</p

Binding interfaces of the DBP-RII∶DARC heterotetramer.

<p>(<b>A</b>) Global view of the DBP-RII∶DARC heterotetramer, showing (<b>B</b>) the DBP-RII homodimeric interface, (<b>C</b>) DARC monomer A interactions, and (<b>D</b>) DARC monomer B interactions. DARC monomer A is in purple, DARC monomer B is in blue, DBP-RII monomer 1 is in green and DBP-RII monomer 2 is in yellow. Residue numbers are labeled and DARC residue labels are underlined.</p

The structural studies define red blood cell binding.

<p>(<b>A</b>) Adherent HEK293 cells in grey bind to darker, smaller red blood cells when transfected with a DBP-RII surface expression plasmid with a GFP marker. Red blood cell rosetting images for DBP-RII mutants, showing bright field (left), GFP (center), and merged images (right). (<b>B</b>) Percentage of cells expressing point mutants which bind red blood cells, relative to wildtype, shown with standard error. (<b>C</b>) The major DBP-RII∶DARC residues identified in the crystal structures are indicated by red dots. Non-conservative <i>P. knowlesi</i> mutations at critical DBP-RII∶DARC contact residues 274, 356, and 363 suggest why PkDBPα but not PkDBPβ or PkDBPγ bind DARC. (<b>D</b>) Red blood cell rosetting images for DBP-RII receptor specificity mutants, showing bright field (left), GFP (center), and merged images (right). (<b>E</b>) Percentage of cells expressing receptor specificity point mutants which bind red blood cells, relative to wildtype, shown with standard error.</p